Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Doolan

Showing results (221-230 of 231) with videos related to

Pageof 24
Sort By:
Science Advances|October 4, 2019
IgM in human immunity to <i>Plasmodium falciparum</i> malariaM J Boyle, J A Chan, I Handayuni, et al.
The Lancet. Microbe|January 3, 2022
Immunomics-guided discovery of serum and urine antibodies for diagnosing urogenital schistosomiasis: a biomarker identification studyMark S Pearson, Bemnet A Tedla, Gebeyaw G Mekonnen, et al.
Plos One|October 18, 2011
Adenovirus 5-vectored P. falciparum vaccine expressing CSP and AMA1. Part A: safety and immunogenicity in seronegative adultsMartha Sedegah, Cindy Tamminga, Shannon McGrath, et al.
Plos One|October 18, 2011
Adenovirus-5-vectored P. falciparum vaccine expressing CSP and AMA1. Part B: safety, immunogenicity and protective efficacy of the CSP componentCindy Tamminga, Martha Sedegah, David Regis, et al.
Ebiomedicine|December 6, 2021
A point-of-care lateral flow assay for neutralising antibodies against SARS-CoV-2Thomas S Fulford, Huy Van, Nicholas A Gherardin, et al.
Human Vaccines & Immunotherapeutics|November 16, 2012
Clinical trial in healthy malaria-naïve adults to evaluate the safety, tolerability, immunogenicity and efficacy of MuStDO5, a five-gene, sporozoite/hepatic stage Plasmodium falciparum DNA vaccine combined with escalating dose human GM-CSF DNAThomas L Richie, Yupin Charoenvit, Ruobing Wang, et al.
Journal of the National Cancer Institute|February 1, 2023
Recommendations for Epstein-Barr virus-based screening for nasopharyngeal cancer in high- and intermediate-risk regionsW K Jacky Lam, Ann D King, Jacob A Miller, et al.
Plos One|March 5, 2013
DNA prime/Adenovirus boost malaria vaccine encoding P. falciparum CSP and AMA1 induces sterile protection associated with cell-mediated immunityIlin Chuang, Martha Sedegah, Susan Cicatelli, et al.
Immunity|May 5, 2021
CD8<sup>+</sup> T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuityThi H O Nguyen, Louise C Rowntree, Jan Petersen, et al.
Nature Communications|April 2, 2021
Systems serology detects functionally distinct coronavirus antibody features in children and elderlyKevin J Selva, Carolien E van de Sandt, Melissa M Lemke, et al.
Pageof 24

Showing results (221-230 of 231) with videos related to

Sort By:
Pageof 24
Science Advances|October 4, 2019
IgM in human immunity to <i>Plasmodium falciparum</i> malariaM J Boyle, J A Chan, I Handayuni, et al.
The Lancet. Microbe|January 3, 2022
Immunomics-guided discovery of serum and urine antibodies for diagnosing urogenital schistosomiasis: a biomarker identification studyMark S Pearson, Bemnet A Tedla, Gebeyaw G Mekonnen, et al.
Plos One|October 18, 2011
Adenovirus 5-vectored P. falciparum vaccine expressing CSP and AMA1. Part A: safety and immunogenicity in seronegative adultsMartha Sedegah, Cindy Tamminga, Shannon McGrath, et al.
Plos One|October 18, 2011
Adenovirus-5-vectored P. falciparum vaccine expressing CSP and AMA1. Part B: safety, immunogenicity and protective efficacy of the CSP componentCindy Tamminga, Martha Sedegah, David Regis, et al.
Ebiomedicine|December 6, 2021
A point-of-care lateral flow assay for neutralising antibodies against SARS-CoV-2Thomas S Fulford, Huy Van, Nicholas A Gherardin, et al.
Human Vaccines & Immunotherapeutics|November 16, 2012
Clinical trial in healthy malaria-naïve adults to evaluate the safety, tolerability, immunogenicity and efficacy of MuStDO5, a five-gene, sporozoite/hepatic stage Plasmodium falciparum DNA vaccine combined with escalating dose human GM-CSF DNAThomas L Richie, Yupin Charoenvit, Ruobing Wang, et al.
Journal of the National Cancer Institute|February 1, 2023
Recommendations for Epstein-Barr virus-based screening for nasopharyngeal cancer in high- and intermediate-risk regionsW K Jacky Lam, Ann D King, Jacob A Miller, et al.
Plos One|March 5, 2013
DNA prime/Adenovirus boost malaria vaccine encoding P. falciparum CSP and AMA1 induces sterile protection associated with cell-mediated immunityIlin Chuang, Martha Sedegah, Susan Cicatelli, et al.
Immunity|May 5, 2021
CD8<sup>+</sup> T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuityThi H O Nguyen, Louise C Rowntree, Jan Petersen, et al.
Nature Communications|April 2, 2021
Systems serology detects functionally distinct coronavirus antibody features in children and elderlyKevin J Selva, Carolien E van de Sandt, Melissa M Lemke, et al.
Pageof 24